ALDVI.PA
Price:
$1.74
Market Cap:
$24.64M
Advicenne S.A., a specialty pharmaceutical company, develops and commercializes treatments for nephrology. Its lead product candidate is Sibnayal for the treatment of distal renal tubular acidosis, as well as for the treatment of cystinuria. Advicenne S.A. was founded in 2007 and is headquartered in Paris, France.
Industry
Biotechnology
IPO Date
2017-12-06
Stock Exchange
PAR
Ticker
ALDVI.PA
According to Advicenne S.A.’s latest financial reports and current stock price. The company's current ROE is 27.34%. This represents a change of 31.04% compared to the average of 20.86% of the last 4 quarters.
The mean historical ROE of Advicenne S.A. over the last ten years is -408.38%. The current 27.34% ROE has changed -106.69% with respect to the historical average. Over the past ten years (40 quarters), ALDVI.PA's ROE was at its highest in in the December 2015 quarter at 112.90%. The ROE was at its lowest in in the June 2015 quarter at -2618.75%.
Average
-408.38%
Median
10.00%
Minimum
-4021.68%
Maximum
225.81%
Discovering the peaks and valleys of Advicenne S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 786.36%
Maximum Annual ROE = 225.81%
Minimum Annual Increase = -305.77%
Minimum Annual ROE = -4021.68%
| Year | ROE | Change |
|---|---|---|
| 2024 | 33.89% | -42.30% |
| 2023 | 58.74% | -46.24% |
| 2022 | 109.27% | -102.72% |
| 2021 | -4021.68% | 786.36% |
| 2020 | -453.73% | 440.86% |
| 2019 | -83.89% | 437.43% |
| 2018 | -15.61% | 12.38% |
| 2017 | -13.89% | -117.98% |
| 2016 | 77.27% | -65.78% |
| 2015 | 225.81% | -305.77% |
The current ROE of Advicenne S.A. (ALDVI.PA) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
67.30%
5-year avg
-854.70%
10-year avg
-408.38%
Advicenne S.A.’s ROE is less than Poxel S.A. (104.21%), less than GenSight Biologics S.A. (54.11%), less than THX Pharma (241.51%), greater than Nicox S.A. (-180.37%), less than genOway S.A. (6.86%), less than Valerio Therapeutics S.A. (975.18%), greater than Aelis Farma S.A. (-101.00%), greater than Valbiotis S.A. (-73.70%), greater than NFL Biosciences S.A. (-127.48%), greater than Ikonisys S.A. (-13.58%),
| Company | ROE | Market cap |
|---|---|---|
| 104.21% | $12.46M | |
| 54.11% | $19.65M | |
| 241.51% | $17.33M | |
| -180.37% | $24.60M | |
| 6.86% | $23.25M | |
| 975.18% | $57.34M | |
| -101.00% | $14.64M | |
| -73.70% | $16.75M | |
| -127.48% | $14.19M | |
| -13.58% | $23.68M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Advicenne S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Advicenne S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Advicenne S.A.'s ROE?
How is the ROE calculated for Advicenne S.A. (ALDVI.PA)?
What is the highest ROE for Advicenne S.A. (ALDVI.PA)?
What is the 3-year average ROE for Advicenne S.A. (ALDVI.PA)?
What is the 5-year average ROE for Advicenne S.A. (ALDVI.PA)?
How does the current ROE for Advicenne S.A. (ALDVI.PA) compare to its historical average?